S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-1.22%) $77.99
Gas
(5.65%) $2.15
Gold
(0.02%) $2 310.10
Silver
(-0.16%) $26.79
Platinum
(0.37%) $966.20
USD/EUR
(-0.35%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.35%) $91.45

实时更新: GH Research PLC [GHRS]

交易所: NASDAQ 部门: Healthcare 工业: Biotechnology
Upcoming Earnings Alert

4 days till quarter result
(bmo 2024-05-09)

Expected move: +/- 9.75%

最后更新时间4 May 2024 @ 04:00

4.38% $ 11.68

Live Chart Being Loaded With Signals

Commentary (4 May 2024 @ 04:00):
Profile picture for GH Research PLC

GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders...

Stats
今日成交量 131 554
平均成交量 123 283
市值 607.69M
EPS $0 ( 2024-03-07 )
下一个收益日期 ( $-0.220 ) 2024-05-09
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -17.18
ATR14 $0.0550 (0.47%)

音量 相关性

長: -0.11 (neutral)
短: -0.72 (moderate negative)
Signal:(47.264) Neutral

GH Research PLC 相关性

10 最正相关
DAVE0.979
GRCL0.974
LGAC0.965
USLM0.964
HERA0.964
ABGI0.963
AGGR0.962
GXII0.962
ACQR0.962
HERAU0.962
10 最负相关
QNRX-0.976
ALHC-0.966
BNRG-0.966
FWRD-0.964
PRTS-0.964
LPSN-0.958
BGFV-0.958
RGF-0.957
SSTI-0.957
APTO-0.956

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

GH Research PLC 相关性 - 货币/商品

The country flag 0.47
( neutral )
The country flag 0.28
( neutral )
The country flag 0.00
( neutral )
The country flag 0.54
( weak )
The country flag 0.25
( neutral )
The country flag 0.14
( neutral )

GH Research PLC 财务报表

Annual 2023
营收: $0
毛利润: $-315 000 (0.00 %)
EPS: $-0.680
FY 2023
营收: $0
毛利润: $-315 000 (0.00 %)
EPS: $-0.680
FY 2022
营收: $0
毛利润: $-47 000.00 (0.00 %)
EPS: $-0.140
FY 2021
营收: $0.00
毛利润: $0.00 (0.00 %)
EPS: $-0.211

Financial Reports:

No articles found.

GH Research PLC

GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH001, an inhalable 5-MeO-DMT product candidate that has completed two Phase 1 clinical trials and Phase 1/2 clinical trial in patients with TRD. The company also develops GH002, an injectable 5-MeO-DMT product candidate; and GH003, an intranasal 5-MeO-DMT product candidate, which are in preclinical development trials with a focus on psychiatric and neurological disorders. GH Research PLC was incorporated in 2018 and is based in Dublin, Ireland.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。